Trial Details
RECRUITINGBasic Information
| Clinical ID | c1626 |
|---|---|
| Identifier | NCT05313620 |
| Trial Title | Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Thromboembolism |
| Interventions | DRUG: Tofacitinib|DRUG: Infliximab Adalimumab y Golimumab |
Participant Information
| Sponsor | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa |
|---|---|
| City | Madrid |
| Country/Region | Spain |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2022-04-01 |
|---|---|
| Primary Completion Date | 2025-12-25 |
| Completion Date | 2025-12-25 |